DIAGNOSTIC BIOCHIPS, INC

Glen Burnie, MD · Founded 2012 · CIK 0001592600 · Medtech · Private

Electrophysiological measurement system for intact brain organoids that captures real-time neural activity

diagnosticbiochips.com →
Grants
$4.5M
7 awards
Sector median: 1
Raised
$1.3M
3 Form D · Mar 2021
67 months since last filing
Contracts
$456K
2 awards · Defense, Health and Human S
#389 of 4531 in medtech
Patents
14
2 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$150,000
Federal grantDepartment of Health and Human Services · Phase I · Indwelling biosensor for real-time chemotherapeutic blood level monitoring$221,891
Federal grantDepartment of Health and Human Services · Phase I · Microfabricated tool for integrated PK/PD studies of CNS drugs$388,069
Federal grantDepartment of Health and Human Services · Phase I · Microfabricated tool for integrated PK/PD studies of CNS drugs$384,470
Federal grantDepartment of Health and Human Services · Phase II · Indwelling Biosensor for real-time chemotherapeutic blood level monitoring$664,149
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Indwelling Biosensor for real time chemotherapeutic blood level monitoring$1,328,298
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Indwelling biosensor for real-time chemotherapeutic blood level monitoring$886,040
Federal grantDepartment of Health and Human Services · Phase II · Indwelling Biosensor for real-time chemotherapeutic blood level monitoring$664,149
Federal contractDepartment of Defense · Igf::ot::igf Electrical Prescriptions (electrx) Seedling Effort. Award For Diagnostic Biochip's Proposal Titled "continuous In Viv Cytokine Monitoring With Electrochemical Aptamer-based Sensors (e-ab's)"$435,994
Private capital raisedForm D · SEC$75,000
Private capital raisedForm D · SEC$1,084,649
Federal contractDepartment of Health and Human Services · Investigational Use Of Diagnostic Biochips Deep Array Probes$20,000
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
386ELUTIA INC.$472K$55M
387INTELLIGENT PROSTHETIC SYSTEMS, LLC$460K—
388CIRCADIAN POSITIONING SYSTEMS INC$457K—
389DIAGNOSTIC BIOCHIPS, INC$456K$1.3M
390Quel Imaging LLC$455K—
391Magnolia Medical Technologies, Inc.$452K$87M
392NANOVIEW BIOSCIENCES, INC.$449K$18M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Greg AldenDirector · Executive Officer
  • Walter Buckley, IIIDirector
  • Robert CollinsDirector · Executive Officer
  • Brian JamiesonDirector · Executive Officer
  • Robert Keith, Jr.Director

Patents

USPTO · 2 granted of 14
  • Devices, Systems, And Methods For Organoid Analysisapplication
  • Integrated Optical Neural Probegranted
  • In Vivo Biosensorgranted
  • Coated Biosensor and Method for Preserving Biosensor During Implantation into the Brain or Other Tissuesapplication
  • Method for the Aptamer Detection of Multiple Small Molecules of Similar Structure Through Deconvolutionapplication
  • In Vivo Biosensorapplication
  • Devices, Systems, And Methods For Organoid Probingapplication
  • Devices, Systems, And Methods For Organoid Analysisapplication
  • Devices, Systems, And Methods For Organoid Probingapplication
  • Method For The Aptamer Detection Of Multiple Small Molecules Of Similar Structure Through Deconvolutionapplication
  • Coated Biosensor And Method For Preserving Biosensor During Implantation Into The Brain Or Other Tissuesapplication
  • Devices, Systems, And Methods For Automatic Probingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.